Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tarsus Pharmaceuticals, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income  -31.4-23.4-22.5-5.7-20.2-14.9-15.76.3
Depreciation and amortization  0.20.10.10.10.00.00.10.1
Stock-based compensation  5.23.93.63.52.72.22.12.8
Change in working capital   [+]3.5-4.63.4-2.31.83.920.64.1
Other operating activities  -1.32.0-3.20.20.4-3.40.07.2
Cash from operations  -23.8-22.0-18.6-4.3-15.3-12.17.120.6
   
Capital expenditures  -0.8-0.3-0.1-0.1-0.2-0.3-0.10.0
Sales of short-term investments, net   [+]64.911.6-57.0     
Cash from investing  64.111.3-57.1-0.1-0.2-0.3-0.10.0
   
Issuance of common stock, net    -0.274.6    
Option exercises  0.50.0 0.2 0.2  
Financing costs     -0.1-0.8   
Other cash from financing  1.05.00.10.318.30.20.10.0
Cash from financing  0.55.0-0.174.719.1-0.10.10.0
   
Free cash flow  -24.6-22.3-18.7-4.4-15.4-12.47.020.5
        Per share (diluted)  ($0.92)($0.83)($0.70)($0.18)($0.75)($0.60)$0.34$0.93
   
Cash paid for interest  0.70.61.0 0.1   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy